fludarabine phosphate has been researched along with Leukemia, Lymphocytic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kantarjian, HM; Keating, MJ; Redman, JR | 1 |
| Berman, E; Warrell, RP | 1 |
| Kufe, DW; Mayer, RJ; Schoene, W; Spriggs, DR; Stopa, E | 1 |
| Bluestein, M; Garewal, H; Greenberg, BR; Habib, MP; Hurst, PG; Paquin, M | 1 |
1 review(s) available for fludarabine phosphate and Leukemia, Lymphocytic
| Article | Year |
|---|---|
Fludarabine phosphate therapy in other lymphoid malignancies.
Topics: Antimetabolites, Antineoplastic; Humans; Leukemia, Lymphoid; Lymphoma; Vidarabine Phosphate | 1990 |
3 other study(ies) available for fludarabine phosphate and Leukemia, Lymphocytic
| Article | Year |
|---|---|
Phase I and II study of fludarabine phosphate in leukemia: therapeutic efficacy with delayed central nervous system toxicity.
Topics: Acute Disease; Adult; Arabinonucleotides; Central Nervous System; Drug Evaluation; Humans; Infusions, Parenteral; Leukemia; Leukemia, Lymphoid; Middle Aged; Nervous System Diseases; Vidarabine Phosphate | 1986 |
Fludarabine phosphate (NSC 312878) infusions for the treatment of acute leukemia: phase I and neuropathological study.
Topics: Acidosis; Adult; Arabinonucleotides; Blindness; Brain Diseases; Coma; Demyelinating Diseases; Dose-Response Relationship, Drug; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Middle Aged; Vidarabine Phosphate | 1986 |
Pulmonary toxicity associated with fludarabine monophosphate.
Topics: Antimetabolites, Antineoplastic; Arabinonucleotides; Humans; Leukemia, Lymphoid; Lung; Male; Middle Aged; Pulmonary Fibrosis; Vidarabine Phosphate | 1987 |